Veloxis Pharmaceuticals to Present Data Differentiating LCP-Tacro™ from ... Sacramento Bee HORSHOLM, Denmark, Oct. 10, 2012 -- /PRNewswire/ -- Veloxis will give two upcoming data presentations that further define the profile of LCP-Tacro compared to other tacrolimus formulations. The first study demonstrates the potentially flexible dosing ... |
